Skiplinks

Medicine put to the test

As an independent scientific institute, IQWiG examines the benefits and harms of medical interventions for patients. We provide information about the advantages and disadvantages of examination and treatment methods in the form of scientific reports and easily understandable health information.

Latest news

Press Releases

Press Releases

Fingolimod in RRMS: indication of added benefit in certain patients

2015-07-01 Based on new analyses conducted by the drug manufacturer, an advantage can be determined in two instead of only one patient group. There are now indications instead of a hint.  read more Link to "Fingolimod in RRMS: indication of added benefit in certain patients"

Vision screening in preschool-aged children: benefit and harm still unclear

2015-06-17 No new screening studies were identified in an update search. The only new treatment study provided no evidence for a benefit of an earlier start of treatment.  read more Link to "Vision screening in preschool-aged children: benefit and harm still unclear"

Aflibercept in macular oedema after branch retinal vein occlusion: no hint of added benefit

2015-06-15 No added benefit can be derived from the dossier because the drug manufacturer presented no relevant data. This is the fourth assessment according to AMNOG that IQWiG has conducted of this drug.  read more Link to "Aflibercept in macular oedema after branch retinal vein occlusion: no hint of added benefit"

Insulin degludec: No hint of added benefit in children and adolescents

2015-06-01 No added benefit for adolescents and children with diabetes mellitus can be derived from the drug manufacturer dossier. In girls with type 1 diabetes, severe side effects were more frequent. read more Link to "Insulin degludec: No hint of added benefit in children and adolescents"

Ultrasound screening for abdominal aortic aneurysms: advantages for men, but not for women

2015-05-28 Men benefit from one-time screening. They live longer because a rupture of the abdominal aorta can be avoided. No such evidence is available for women.  read more Link to "Ultrasound screening for abdominal aortic aneurysms: advantages for men, but not for women"

loading …

Current commenting procedures (Hearings)

Current commenting procedures (Hearings)

No. Title Type Deadline
D13-01 Urine proteomic analysis for detection of diabetic nephropathy in patients with diabetes mellitus and arterial hypertension on the preliminary report 2015-07-06

Commissions advertised

Commissions advertised

Currently no commissions advertised.


Easily understandable information for patients and the general community

Fixed combination of tafluprost / timolol (Taptiqom) for glaucoma

The fixed combination of the active ingredients tafluprost and timolol (trade name: Taptiqom) has been approved in Germany since December 2014 for the treatment of open-angle glaucoma or increased intraocular pressure in adults.  read more (Link to "Fixed combination of tafluprost / timolol (Taptiqom) for glaucoma" – opens in a new window)

to top

Glossary entries